Table 3.

Baseline patients’ characteristics in the included publications

Ref.	Age (yr)	Sex (male/female)	Origin of the study population	No. HCC	No. non HCC
Ainora et al[5], 2023	68 ± 11	55/27	Cirrhotic and non-cirrhotic patients	38	44
Dong et al[15], 2023	59.4 ± 8.6 (ICC)	27/27	Non-cirrhotic patients	24	30
	60.9 ± 12.1 (HCC)
Wildner et al[23], 2019	63.8 ± 12.6	84/64	Cirrhotic and non-cirrhotic patients	41	107
Wildner et al[17], 2014	67	30/13	Cirrhotic and non-cirrhotic patients	23	20

HCC: Hepatocellular carcinoma; ICC: Intracellular cholangiocarcinoma.